The molecular aetiology of central obesity: moving from variant to function using large-scale data-driven approaches.

Around the world, people are dying from illnesses driven by fat stored deep in the abdomen—yet doctors still lack effective ways to prevent or treat this dangerous pattern of weight gain. Current strategies for tackling central obesity—the kind that wraps around internal organs—are failing. The condition is a leading cause of illness and death globally, but its underlying biology remains poorly understood. This project aims to change that by combining human genetics with detailed molecular analysis of fat cells, an approach known as multi-omics. If successful, the research will reveal the fundamental biological processes that cause fat to accumulate centrally. This knowledge could eventually lead to more targeted preventative measures or treatments that reduce the burden of obesity-related diseases such as type 2 diabetes and heart disease. The work is fundamental science—it will not produce a new drug or diet plan tomorrow. But similar genetic and molecular studies have, in the past, uncovered unexpected drug targets and transformed how clinicians understand and treat metabolic conditions. Deeper insight into why some people store fat around their organs while others do not could reshape future therapeutic strategies.